Absence of system xc- in mice decreases anxiety and depressive-like behavior without affecting sensorimotor function or spatial vision.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Progress in Neuro-psychopharmacology and Biological Psychiatry

• Publication date

  2015-06-03

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/j.pnpbp.2015.01.010PMID 25619129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

  2014cited by this paper
• Sensory aspects of movement disorders.

  2014cited by this paper
• Cerebellum involvement in cortical sensorimotor circuits for the control of voluntary movements

  2014cited by this paper
• Environmental enrichment eliminates the anxiety phenotypes in a triple transgenic mouse model of Alzheimer’s disease

  2014cited by this paper
• Behavioral assessment of acute inhibition of system xc- in rats

  2014cited by this paper
• Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants

  2013cited by this paper
• The medial habenula: still neglected

  2013cited by this paper
• Glutamate-based antidepressants: preclinical psychopharmacology.

  2013cited by this paper
• From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders.

  2013cited by this paper
• New paradigms for treatment‐resistant depression

  2013cited by this paper
• 50 years of hurdles and hope in anxiolytic drug discovery

  2013cited by this paper
• Dysfunctional astrocytic regulation of glutamate transmission in a rat model of depression

  2013cited by this paper
• Power failure: why small sample size undermines the reliability of neuroscience

  2013cited by this paper
• Significant increase in anxiety during aging in mGlu5 receptor knockout mice.

  2013cited by this paper
• The Cystine/Glutamate Antiporter System xc − in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities

  2013influential reference
• Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development

  2012cited by this paper
• Short and Long Term Measures of Anxiety Exhibit Opposite Results

  2012cited by this paper
• Vision and visual plasticity in ageing mice

  2012cited by this paper
• Use of the Cassette-Dosing Approach to Assess Brain Penetration in Drug Discovery

  2012cited by this paper
• Thinking Outside the Cleft to Understand Synaptic Activity: Contribution of the Cystine-Glutamate Antiporter (System xc−) to Normal and Pathological Glutamatergic Signaling

  2012cited by this paper
• The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission

  2011cited by this paper
• Dopaminergic neurons of system xc–‐deficient mice are highly protected against 6‐hydroxydopamine‐induced toxicity

  2011cited by this paper
• The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.

  2011cited by this paper
• Focus on molecules: the cystine/glutamate exchanger (System x(c)(-)).

  2011cited by this paper
• Loss of System xc− Does Not Induce Oxidative Stress But Decreases Extracellular Glutamate in Hippocampus and Influences Spatial Working Memory and Limbic Seizure Susceptibility

  2011cited by this paper
• Glutamatergic modulators: the future of treating mood disorders?

  2010cited by this paper
• Sex, trauma, stress hormones and depression

  2010cited by this paper
• Anxiety and depression in the elderly: do we know any more?

  2010cited by this paper
• Peculiarities of Geriatric Psychiatry: A Focus on Aging and Depression

  2010cited by this paper
• he participation of a neurocircuit from the paraventricular thalamus to mygdala in the depressive like behavior

  2010cited by this paper
• Glutamate, Excitatory Amino Acid Transporters, Xc− Antiporter, Glutamine Synthetase, and γ-Glutamyltranspeptidase in Human Corneal Epithelium

  2010cited by this paper
• Effects of hyperglycemia and oxidative stress on the glutamate transporters GLAST and system xc− in mouse retinal Müller glial cells

  2009cited by this paper
• Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment.

  2009cited by this paper
• The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice

  2009cited by this paper
• Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

  2008cited by this paper
• Behavioral phenotyping strategies for mutant mice.

  2008cited by this paper
• Animal models of anxiety: do I need multiple tests?

  2008cited by this paper
• Characterization of the cystine/glutamate transporter in the outer plexiform layer of the vertebrate retina

  2008cited by this paper
• Antidepressant-like effects of ceftriaxone in male C57BL/6J mice.

  2007cited by this paper
• Translational Research in Late-Life Mood Disorders: Implications for Future Intervention and Prevention Research

  2007cited by this paper
• Use of a platform in an automated open-field to enhance assessment of anxiety-like behaviors in mice.

  2007cited by this paper
• Cystine/Glutamate Exchange Modulates Glutathione Supply for Neuroprotection from Oxidative Stress and Cell Proliferation

  2006cited by this paper
• Assessing nest building in mice

  2006cited by this paper
• Expression of the cystine-glutamate exchanger (xc−) in retinal ganglion cells and regulation by nitric oxide and oxidative stress

  2006cited by this paper
• Distribution of the Cystine/Glutamate Antiporter System x− c in the Brain, Kidney, and Duodenum

  2006cited by this paper
• Molecular characterization of the cystine/glutamate exchanger and the excitatory amino acid transporters in the rat lens.

  2005cited by this paper
• Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system

  2005cited by this paper
• Redox Imbalance in Cystine/Glutamate Transporter-deficient Mice*

  2005cited by this paper
• Anxiety and its disorders in late life: moving the field forward.

  2005cited by this paper
• Model organisms: The ascent of mouse: advances in modelling human depression and anxiety

  2005cited by this paper
• Cystine/Glutamate Exchange Regulates Metabotropic Glutamate Receptor Presynaptic Inhibition of Excitatory Transmission and Vulnerability to Cocaine Seeking

  2005cited by this paper
• Metabotropic glutamate receptors as novel targets for anxiety and stress disorders

  2005cited by this paper
• Glutamate and anxiety.

  2004cited by this paper
• Behavioral alterations induced by repeated testing in C57BL/6J and 129S2/Sv mice: implications for phenotyping screens

  2004cited by this paper
• Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression

  2004cited by this paper
• Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system.

  2004cited by this paper
• The tail suspension test: A new method for screening antidepressants in mice

  2004cited by this paper
• Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse

  2003cited by this paper
• In search of a better mouse test.

  2003cited by this paper
• The Novel Neuroprotective Action of Sulfasalazine through Blockade of NMDA Receptors

  2003cited by this paper
• Distribution of Cystine/Glutamate Exchange Transporter, System xc−, in the Mouse Brain

  2002cited by this paper
• Assessing antidepressant activity in rodents: recent developments and future needs.

  2002cited by this paper
• The Origin and Neuronal Function of In Vivo Nonsynaptic Glutamate

  2002cited by this paper
• Area postrema lesions elevate NPY levels and decrease anxiety-related behavior in rats.

  2002cited by this paper
• Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells.

  2001cited by this paper
• QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice

  2001cited by this paper
• Glutamate uptake.

  2001cited by this paper
• Intra- and interstrain differences in models of "behavioral despair".

  2001cited by this paper
• QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice.

  2001cited by this paper
• Genetics of mouse behavior: interactions with laboratory environment.

  1999cited by this paper
• Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats.

  1999cited by this paper
• Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.

  1998cited by this paper
• A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice.

  1997cited by this paper
• Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze.

  1995cited by this paper
• Cystine/glutamate antiporter expression in retinal Müller glial cells: implications for DL-alpha-aminoadipate toxicity.

  1993cited by this paper
• Depression: a new animal model sensitive to antidepressant treatments

  1977cited by this paper

• Astroglial kappa opioid receptor-mediated reduction of glutamate exchanger xCT in the prelimbic cortex underlies chronic stress-induced depressive-like behaviors.

  2025cites this paper
• Intact corticostriatal function in aged system xc- - deficient mice

  2025cites this paper
• Dapagliflozin Reverses LPS‐Induced Depressive–Like Behavior in Mice via Modulation of Glutamate and NF‐κB

  2025cites this paper
• Guardian of myelin and neural Integrity: foxo1a through slc7a11 mitigating oxidative damage in myelin

  2025cites this paper
• Compartmentalized role of xCT in supporting pancreatic tumor growth, inflammation and mood disturbance in mice.

  2024influential citation
• Inhibition of xCT by sulfasalazine alleviates the depression-like behavior of adult male mice subjected to maternal separation stress.

  2023cites this paper
• Characterization of the long-term effects of lethal total body irradiation followed by bone marrow transplantation on the brain of C57BL/6 mice

  2023cites this paper
• Sex- and age-dependent contribution of System xc– to cognitive, sensory, and social behaviors revealed by comprehensive behavioral analyses of System xc– null mice

  2023influential citation
• Revealing the contribution of astrocytes to glutamatergic neuronal transmission

  2023cites this paper
• Under or Absent Reporting of Light Stimuli in Testing of Anxiety-Like Behaviors in Rodents: The Need for Standardization

  2022cites this paper
• Is depression the missing link between inflammatory mediators and cancer?

  2022cites this paper
• Lifespan extension with preservation of hippocampal function in aged system xc−-deficient male mice

  2022cites this paper
• Chronic Sulfasalazine Treatment in Mice Induces System xc − - Independent Adverse Effects

  2021influential citation
• Influence of glutamate and GABA transport on brain excitatory/inhibitory balance

  2021cites this paper
• Corticostriatal dysfunction and social interaction deficits in mice lacking the cystine/glutamate antiporter

  2020cites this paper
• Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues

  2020influential citation
• Drug-responsive autism phenotypes in the 16p11.2 deletion mouse model: a central role for gene-environment interactions

  2020cites this paper
• Blocking Astrocytic GABA Restores Synaptic Plasticity in Prefrontal Cortex of Rat Model of Depression

  2020cites this paper
• Effects of neuromedin U-8 on stress responsiveness and hypothalamus-pituitary-adrenal axis activity in male C57BL/6J mice.

  2019cites this paper
• Systemic LPS-induced neuroinflammation increases the susceptibility for proteasome inhibition-induced degeneration of the nigrostriatal pathway.

  2019cites this paper
• Slc7a11 (xCT) protein expression is not altered in the depressed brain and system xc- deficiency does not affect depression-associated behaviour in the corticosterone mouse model

  2019cites this paper
• Genetic deletion of xCT attenuates peripheral and central inflammation and mitigates LPS‐induced sickness and depressive‐like behavior in mice

  2018cites this paper
• Modelling oxidative stress in human hippocampal progenitor cells : insight into the pathogenesis of depression and antidepressants action

  2017cites this paper
• Decreased reproductive performance in xCT-knockout male mice

  2017cites this paper
• Investigating neurobiological mechanisms linking depression and inflammation

  2017cites this paper
• Vibrational Spectroscopy of Nucleic Acids

  2017cites this paper
• Selective changes in locomotor activity in mice due to low-intensity microwaves amplitude modulated in the EEG spectral domain.

  2017cites this paper
• Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression

  2017cites this paper
• In-depth behavioral characterization of the corticosterone mouse model and the critical involvement of housing conditions.

  2016cites this paper
• Studies on the Pathophysiology of Cancer-Induced Depression

  2016cites this paper
• Comparative analysis of antibodies to xCT (Slc7a11): Forewarned is forearmed

  2016cites this paper
• N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington's disease.

  2016cites this paper
• Hyperforin alleviates mood deficits of adult rats suffered from early separation.

  2015cites this paper
• Overview of Glutamatergic Dysregulation in Central Pathologies

  2015cites this paper
• Main path and byways: non‐vesicular glutamate release by system xc− as an important modifier of glutamatergic neurotransmission

  2015influential citation